Yes, there is a correlation between usage of 100Plus RPM and improved physiologic parameters.
In 2019, Medicare and other payers began reimbursing for RPM in a bet that clinicians would be better equipped to deliver preventative care to their patients with chronic conditions if they were armed with higher resolution physiologic data from between appointments.
To assess our performance toward this mission, we performed an aggregated, de-identified, retrospective quality improvement analysis of 18,555 100Plus RPM patients across 344 practices. We focused on three key metrics: (1) blood pressure control, (2) blood glucose control in diabetic patients, and (3) weight loss in patients who weighed > 220 lbs and > 286 lbs. The mean improvement in clinical parameters over patients’ first 180 days is below.
Hypertension: Patients' systolic BP dropped by 4.7 mmHg from 141.0 to 136.3 mmHg; patients’ diastolic BP dropped 3.5 mmHg from 79.1 to 75.6 mmHg (n = 9,219; p < 0.0000001).
Obesity: patients starting > 286 lbs lost 8.2 lbs (n = 139; p < 0.0000001)
Diabetes: patients’ random glucose dropped 7.5 mg/dL (n = 2,324; p < 0.000001)
We additionally reviewed the results of health care provider surveys on the impact of 100Plus RPM on patient care and discuss the potential effects on health outcomes and costs; there were no monetary incentives for responses:
69% of providers believe 100Plus RPM has reduced or greatly reduced the incidence of hospitalizations and other forms of high acuity care.
% of providers who believe that 100Plus RPM has improved or greatly improved...
Blood Pressure control in hypertension 94%
Hemoglobin a1C control in diabetes 75%
Achievement guideline-directed medical therapy (GDMT) in heart failure 69%
Weight loss in obese patients 34%